Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The aim of the current study is to compare miscarriage rates (before 8 weeks) between a true
natural cycle (awaiting spontaneous LH surge) and a hormone replacement therapy cycle prior
to blastocyst transfer in preimplantation genetic testing (PGT) patients, with biopsy on day
5 of embryonic development. The advantage of performing the study in PGT patients is the
exclusion of aneuploidy as a cause of miscarriage.